ChemicalBook--->CAS DataBase List--->1211527-23-9

1211527-23-9

1211527-23-9 Structure

1211527-23-9 Structure
IdentificationBack Directory
[Name]

NORFENTANYL-D5 OXALATE
[CAS]

1211527-23-9
[Synonyms]

Norfentanyl-d5 (CRM)
NORFENTANYL-D5 OXALATE
Norfentanyl-D5 oxalate solution
[EINECS(EC#)]

200-659-6
[Molecular Formula]

C14H15D5N2O
[MDL Number]

MFCD08272800
[MOL File]

1211527-23-9.mol
[Molecular Weight]

237.36
Chemical PropertiesBack Directory
[Fp ]

9℃
[storage temp. ]

-20°C
[form ]

A neat solid
Safety DataBack Directory
[Hazard Codes ]

F,T
[Risk Statements ]

11-23/24/25-39/23/24/25
[Safety Statements ]

7-16-36/37-45
[RIDADR ]

UN1230 - class 3 - PG 2 - Methanol, solution
[WGK Germany ]

1
Hazard InformationBack Directory
[Description]

Norfentanyl-d5 (hydrochloride) (Item No. 15832) is intended for use as an internal standard for the quantification of norfentanyl by GC- or LC-mass spectrometry. Norfentanyl is a thermal degradant and major urinary metabolite of the opioid analgesic, fentanyl (Item Nos. ISO60197 | 14719). This product is intended for forensic and research applications.
[Description]

Norfentanyl-d5 (hydrochloride) (Item No. 15832) is intended for use as an internal standard for the quantification of norfentanyl by GC- or LC-MS. Norfentanyl is a thermal degradant and major urinary metabolite of the opioid analgesic, fentanyl (Item Nos. ISO60197 | 14719). This product is intended for forensic and research applications.
[General Description]

An internal standard suitable for norfentanyl testing of urine, blood, or hair samples or isotope dilution methods by GC/MS or LC/MS in applications such as pain prescription monitoring, clinical toxicology, urine drug testing, or forensic analysis. Norfentanyl is a major urinary metabolite of fentanyl, a potent synthetic analgesic sold under various trade names including Sublimaze, Duragesic?, Actiq?, and Fentora?.
[References]

[1] ANURADHA GARG. Forced degradation of fentanyl: Identification and analysis of impurities and degradants[J]. Journal of pharmaceutical and biomedical analysis, 2010, 53 3: Pages 325-334. DOI: 10.1016/j.jpba.2010.04.004
[2] ALPHONSE POKLIS  Ronald B. Urine concentrations of fentanyl and norfentanyl during application of Duragesic transdermal patches.[J]. Journal of analytical toxicology, 2004, 28 6: 422-425. DOI: 10.1093/jat/28.6.422
1211527-23-9 suppliers list
Tags:1211527-23-9 Related Product Information
1432-04-8 2701720-35-4 1609-66-1 1046436-53-6 2748343-79-3